KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Other Operating Expenses (2016 - 2025)

Resmed (RMD) has disclosed Other Operating Expenses for 17 consecutive years, with $11.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 6.49% year-over-year to $11.8 million, compared with a TTM value of $46.5 million through Dec 2025, down 57.36%, and an annual FY2023 reading of $20.2 million, changed N/A over the prior year.
  • Other Operating Expenses was $11.8 million for Q4 2025 at Resmed, down from $12.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $75.5 million in Q2 2024 and bottomed at $7.4 million in Q1 2021.
  • Average Other Operating Expenses over 5 years is $13.5 million, with a median of $11.1 million recorded in 2024.
  • The sharpest move saw Other Operating Expenses surged 435.65% in 2024, then tumbled 84.2% in 2025.
  • Year by year, Other Operating Expenses stood at $7.7 million in 2021, then rose by 23.74% to $9.6 million in 2022, then grew by 20.91% to $11.6 million in 2023, then dropped by 4.57% to $11.0 million in 2024, then rose by 6.49% to $11.8 million in 2025.
  • Business Quant data shows Other Operating Expenses for RMD at $11.8 million in Q4 2025, $12.0 million in Q3 2025, and $11.9 million in Q2 2025.